skullcapflavone I: from Scutellaria baicalensis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Scutellaria | genus | A plant genus of the family Lamiaceae used in folk medicine.[MeSH] | Lamiaceae | The mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH] |
| Scutellaria baicalensis | species | A plant species of the genus Scutellaria, family LAMIACEAE, that contains skullcap flavone and is used in CHINESE HERBAL DRUGS.[MeSH] | Lamiaceae | The mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 5320399 |
| SCHEMBL ID | 6069761 |
| MeSH ID | M0493266 |
| Synonym |
|---|
| panicolin |
| skullcapflavone i |
| LMPK12111304 |
| 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxychromen-4-one |
| 2',5-dihydroxy-7,8-dimethoxyflavone |
| 8P86A8Q1G0 , |
| 4h-1-benzopyran-4-one, 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy- |
| 55084-09-8 |
| 5,2'-dihydroxy-7,8-dimethoxyflavone |
| unii-8p86a8q1g0 |
| 41060-16-6 |
| SCHEMBL6069761 |
| skullcapflavonei |
| skullcapflavone i, analytical standard |
| AKOS032961992 |
| FS-9871 |
| Q27270850 |
| HY-N1235 |
| CS-0016636 |
Skullcapflavone I is a flavone compound extracted from Scutellaria baicalensis Georgi (Wogon)
| Excerpt | Reference | Relevance |
|---|---|---|
| "Skullcapflavone I is a flavone compound extracted from Scutellaria baicalensis Georgi (Wogon)." | ( Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21. An, R; Bo, Y; Feng, T; Niu, B; Qin, X; Yang, Y; Zhang, J, 2019) | 2.68 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.68) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||